Clover Leaf Capital Corp. (CLOEU)
USD 11.0
(0.0%)
USD 11.0
(0.0%)
| Breakdown | 2023 | 2022 | 2021 |
|---|---|---|---|
| Revenue | - | - | - |
| Cost of Revenue | 1.58 Million | 1.29 Million | - |
| Gross Profit | -1.58 Million | -1.29 Million | - |
| Operating Expenses | 1.58 Million | 1.29 Million | 851.77 Thousand |
| Selling, General and Administrative Expenses | 1.58 Million | 1.29 Million | 851.77 Thousand |
| Research and Development Expenses | - | - | - |
| Other Expenses | - | 1.29 Million | - |
| Cost and Expenses | 1.58 Million | 1.29 Million | 851.77 Thousand |
| Operating Income | -1.58 Million | -1.29 Million | -851.78 Thousand |
| Interest Expense | - | - | - |
| Income Tax Expense | 196.59 Thousand | 185.42 Thousand | -1022.13 |
| Earnings before Tax | -849.36 Thousand | 245.66 Thousand | -834.08 Thousand |
| Net Income | -1.04 Million | 60.23 Thousand | -834.08 Thousand |
| Earnings Per Share Basic | -0.18 | 0.00 | -0.05 |
| Earnings Per Share Diluted | -0.18 | 0.00 | -0.05 |
| Weighted Average Shares Outstanding | 5.72 Million | 15.66 Million | 18.1 Million |
| Weighted Average Shares Outstanding (Diluted) | 5.72 Million | 15.66 Million | 18.1 Million |
| Gross Margin | - | - | - |
| EBIT Margin | - | - | - |
| Profit Margin | - | - | - |
| EBITDA | 737.17 Thousand | -1.29 Million | 21.22 Thousand |
| Earnings Before Tax Margin | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 446.43 Thousand | 450.59 Thousand | 218.42 Thousand | 1.58 Million | 468.11 Thousand | 709.83 Thousand |
| Gross Profit | -446.43 Thousand | -450.59 Thousand | -218.42 Thousand | -1.58 Million | -468.11 Thousand | -709.83 Thousand |
| Operating Expenses | 446.43 Thousand | 450.59 Thousand | 367.42 Thousand | 1.58 Million | 468.11 Thousand | 709.83 Thousand |
| Selling, General and Administrative Expenses | 446.43 Thousand | 450.59 Thousand | 367.42 Thousand | - | 468.11 Thousand | 709.83 Thousand |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 446.43 Thousand | - | -190.17 Thousand | - | - | - |
| Cost and Expenses | 446.43 Thousand | 450.59 Thousand | 367.42 Thousand | 1.58 Million | 468.11 Thousand | 709.83 Thousand |
| Operating Income | -446.44 Thousand | -450.59 Thousand | -367.42 Thousand | -1.58 Million | -468.11 Thousand | -709.83 Thousand |
| Interest Expense | 8814.00 | - | 116.12 Thousand | - | - | - |
| Income Tax Expense | 26.71 Thousand | 26.94 Thousand | 30.06 Thousand | 196.59 Thousand | -77.72 Thousand | 47.22 Thousand |
| Earnings before Tax | -323.52 Thousand | -316.19 Thousand | -215.67 Thousand | -849.36 Thousand | -304.11 Thousand | -487.69 Thousand |
| Net Income | -350.23 Thousand | -343.13 Thousand | -245.73 Thousand | -1.04 Million | -381.84 Thousand | -534.91 Thousand |
| Earnings Per Share Basic | -0.07 | -0.06 | -0.04 | - | -0.07 | -0.09 |
| Earnings Per Share Diluted | -0.07 | -0.06 | -0.04 | - | -0.07 | -0.09 |
| Weighted Average Shares Outstanding | 5.32 Million | 5.36 Million | 5.52 Million | 5.72 Million | 5.6 Million | 5.89 Million |
| Weighted Average Shares Outstanding (Diluted) | 5.32 Million | 5.36 Million | 5.52 Million | 5.72 Million | 5.6 Million | 5.89 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -446.44 Thousand | -450.59 Thousand | -367.42 Thousand | - | -468.11 Thousand | -709.83 Thousand |
| Earnings Before Tax Margin | - | - | - | - | - | - |
ARBE
V2Y
1529
1725
600830
PARB